PCM
MD icon

Palisade Capital Management’s Pediatrix Medical MD Stock Holding History

Palisade Capital Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-823,340
Closed -$10.5M – 378
2023
Q3 		$10.5M Buy
823,340
+12,352
+2% +$170K 0.29% 104
2023
Q2 		$11.5M Buy
810,988
+38,708
+5% +$544K 0.31% 103
2023
Q1 		$11.5M Buy
772,280
+29,991
+4% +$454K 0.31% 105
2022
Q4 		$11M Sell
742,289
-27,602
-4% -$450K 0.3% 113
2022
Q3 		$12.7M Buy
769,891
+150,357
+24% +$3.03M 0.36% 93
2022
Q2 		$13M Buy
619,534
+6,785
+1% +$138K 0.35% 89
2022
Q1 		$14.4M Sell
612,749
-36,176
-6% -$886K 0.33% 101
2021
Q4 		$17.7M Buy
648,925
+5,770
+0.9% +$154K 0.36% 92
2021
Q3 		$18.3M Buy
643,155
+56,130
+10% +$1.71M 0.4% 87
2021
Q2 		$17.7M Sell
587,025
-182,144
-24% -$5.38M 0.4% 92
2021
Q1 		$19.6M Buy
769,169
+24,334
+3% +$623K 0.46% 74
2020
Q4 		$18.3M Sell
744,835
-28,683
-4% -$539K 0.47% 76
2020
Q3 		$12.6M Buy
773,518
+29,722
+4% +$553K 0.37% 95
2020
Q2 		$12.7M Buy
743,796
+2,753
+0.4% +$40.8K 0.4% 90
2020
Q1 		$8.63M Sell
741,043
-73,292
-9% -$1.51M 0.3% 110
2019
Q4 		$22.6M Buy
814,335
+15,682
+2% +$393K 0.64% 48
2019
Q3 		$18.1M Buy
798,653
+54,896
+7% +$1.25M 0.55% 62
2019
Q2 		$18.8M Buy
743,757
+81,537
+12% +$2.19M 0.58% 60
2019
Q1 		$18M Buy
662,220
+112,898
+21% +$3.79M 0.58% 54
2018
Q4 		$18.1M Buy
549,322
+7,896
+1% +$317K 0.66% 44
2018
Q3 		$25.3M Buy
541,426
+31,606
+6% +$1.45M 0.7% 43
2018
Q2 		$22.1M Buy
509,820
+127,171
+33% +$6.09M 0.64% 47
2018
Q1 		$21.3M Sell
382,649
-147,696
-28% -$8.1M 0.72% 36
2017
Q4 		$28.3M Sell
530,345
-20,404
-4% -$963K 0.96% 16
2017
Q3 		$23.7M Buy
550,749
+18,841
+4% +$895K 0.85% 26
2017
Q2 		$32.1M Sell
531,908
-25,961
-5% -$1.54M 1.2% 6
2017
Q1 		$38.7M Sell
557,869
-27,444
-5% -$1.91M 1.48% 3
2016
Q4 		$39M Sell
585,313
-3,058
-0.5% -$199K 1.46% 3
2016
Q3 		$39M Buy
588,371
+9,004
+2% +$616K 1.39% 2
2016
Q2 		$42M Buy
579,367
+5,878
+1% +$404K 1.52% 1
2016
Q1 		$37.1M Buy
573,489
+60,932
+12% +$4.04M 1.21% 3
2015
Q4 		$36.7M Buy
512,557
+72,975
+17% +$5.4M 1.19% 3
2015
Q3 		$33.8M Sell
439,582
-17,839
-4% -$1.44M 0.99% 7
2015
Q2 		$33.9M Buy
457,421
+6,437
+1% +$463K 0.86% 8
2015
Q1 		$32.7M Buy
450,984
+1,297
+0.3% +$90.2K 0.82% 9
2014
Q4 		$29.7M Buy
449,687
+6,063
+1% +$370K 0.72% 16
2014
Q3 		$24.3M Buy
443,624
+13,381
+3% +$759K 0.62% 25
2014
Q2 		$25M Sell
430,243
-1,519
-0.4% -$89.4K 0.61% 27
2014
Q1 		$26.8M Sell
431,762
-61,938
-13% -$3.6M 0.66% 23
2013
Q4 		$26.4M Sell
493,700
-6,390
-1% -$343K 0.69% 20
2013
Q3 		$25.1M Sell
500,090
-780
-0.2% -$38.1K 0.68% 20
2013
Q2 		$22.9M Buy
+500,870
New +$22.4M 0.66% 20

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Palisade Capital Management's MD Position: Q4 2023 in Review

Palisade Capital Management sold out of Pediatrix Medical (MD) in Q4 2023, closing a stake of 823,340 shares — an estimated $10.5M sold.

Palisade Capital Management first reported a position in MD in Q2 2013 and held it in 42 quarters. The position peaked at $42M in Q2 2016. 223 funds tracked by Wall St. Rank hold MD as of Q4 2023.

  • Palisade Capital Management reported no remaining Pediatrix Medical position as of Q4 2023 after selling out during the quarter.
  • Palisade Capital Management sold 823,340 Pediatrix Medical shares in Q4 2023, an estimated $10.5M.
  • Palisade Capital Management first reported a position in Pediatrix Medical in Q2 2013 and held it in 42 quarters.
  • Palisade Capital Management's Pediatrix Medical position peaked at $42M in Q2 2016.
  • 223 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2023.

Based on Palisade Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.